The special salon on smart hospital construction was successfully held

The special salon on smart hospital construction was successfully held

special salon seminar on smart hospital construction sponsored by the Beijing Hospital Construction Association was held grandly at the Beijing Human Health Hotel. More than 30 people, including colleagues from infrastructure and general affairs of various hospitals, participated in the salon discussion.

04

2023

/

07

Exhibition Direct | Pay attention to the grand medical scene on the same day as CHCC2023

Exhibition Direct | Pay attention to the grand medical scene on the same day as CHCC2023

On June 17, the 24th National Hospital Construction Conference and International Hospital Construction, Equipment and Management Exhibition (CHCC2023 for short) was grandly held in Chengdu West China International Expo City!

04

2023

/

07

A robot that can "breathe, sweat, and tremble" is born

A robot that can "breathe, sweat, and tremble" is born

Since the birth of ChatGPT, robots on the road from machines to humans have become more and more like humans. The once cold machines can now not only do what people do, but also speak what people say, have skin that can be touched by people, and can even read people's emotions and have "empathy" with people.

16

2023

/

06

Strategies to improve CAR-T cell dysfunction

Strategies to improve CAR-T cell dysfunction

Over the past decade, we have made significant progress in improving the efficacy of CAR-T cell therapies. However, its clinical benefit remains limited, especially in solid tumors. Even among hematological malignancies, patients who respond to CAR-T therapy are still at risk of relapse due to multiple factors. This is due to the frequent dysfunction of T cells, especially CAR-T cells, in cancer, and many evasion mechanisms impair anti-tumor immunity.

16

2023

/

06

It’s 2023, is PD-1 still worth paying attention to?

It’s 2023, is PD-1 still worth paying attention to?

The huge indication group (effective against both hematological tumors and solid tumors) once made PD-1 the most popular anti-cancer target. What followed was an influx of many domestic pharmaceutical companies.

16

2023

/

06

< 1234 >

Leave us a

message

If you have found your desired products or want to design your exclusive products, 
please feel free to contact, we are here for you 24/7.

Submit →
%{tishi_zhanwei}%